The invention provides bispecific polypeptides comprising a first binding domain designated B7 which is capable of binding specifically to CD137 and a second binding domain designated B2 which is capable of specifically binding to a tumour cell-associated antigen. Also provided are pharmaceutical compositions of such bispecific polypeptides and uses of the same in medicine.